Obagi Nu-Derm Sunfader SPF 15
Obagi Nu-Derm Sunfader SPF 15 provides UV protection to help stop sun damage, which can cause hyperpigmentation and signs of aging. This customer favorite also includes hydroquinone 4% prescribed to fade hyperpigmentation such as melasma, sun spots, scars left by acne and blemishes as well as other types of skin discoloration.
All-In-One SPF And Skin Lightener By Obagi
Give your skin some help with Obagi Nu-Derm Sunfader! Obagi Nu-Derm Sunfader SPF 15 contains a one-of-a-kind combination of ingredients to lighten hyperpigmented skin and protect skin from additional sun damage. Octinoxate and oxybenzone provide UV protection SPF 15 to help stop premature aging from over-exposure to the sun. Sun damage, also called photo-damage, hampers the ability of the skin to regenerate itself and causes hyperpigmentation, wrinkles, rough skin and worse.
In addition to the effective sun protection Obagi Sunfader Rx-only provides, it also contains topical prescription-strength 4% hydroquinone. Hydroquinone, a skin lightening agent, is one of the best treatments for hyperpigmentation. It hinders pigment cell production to lighten dark spots and correct uneven skin surface color. The result is a bright, clear complexion.
Obagi Nu-Derm Sunfader with 4% hydroquinone and SPF 15 is ideal for people who get more sun exposure than normal on a daily basis.
Contains 4% hydroquinone. Use sunscreen when exposed to sun.
CONTRAINDICATIONS: People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
WARNINGS :Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
PRECAUTIONS (ALSO SEE WARNINGS):Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.
Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.
Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established.
Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.